TY - JOUR
T1 - Leishmanicidal constituents from the leaves of Piper rusbyi
AU - Flores, Ninoska
AU - Cabrera, Gabriela
AU - Jiménez, Ignacio A.
AU - Piñero, Jose
AU - Giménez, Alberto
AU - Bourdy, Genevieve
AU - Cortés-Selva, Fernando
AU - Bazzocchi, Isabel López
PY - 2007/3
Y1 - 2007/3
N2 - The kavapyrone (+)-(7R,8S)-epoxy-5,6-didehydrokavain (1) and the chalcone flavokavain B (2) were isolated from Piper rusbyi as the bioactive components by bioassay-guided fractionation, using an in vitro assay against promastigote forms of three Leishmania strains. In addition, the new kavapyrone, (7R,8R/7S,8S)-dihydroxy-5,6-didehydrokavain (3), which is very likely an artifact, and four known compounds (4-7) were isolated. Their structures were elucidated on the basis of spectral analysis, and the absolute configurations of compounds 1 and 3 were established by CD studies and the modified Mosher ester procedure, respectively. All compounds were evaluated for in vitro leishmanicidal activity. The most active compounds 1 (IC50 = 81.9 μM) and 2 (IC50 = 11.2 μM) were also evaluated in vivo against a New World strain of cutaneous leishmaniasis, and the results showed the efficacy of 2 at a dose of 5 mg/kg/day. Compounds 1 and 3 were also assayed as reversal agents against a multidrug-resistant Leishmania tropica line, but were found to be inactive.
AB - The kavapyrone (+)-(7R,8S)-epoxy-5,6-didehydrokavain (1) and the chalcone flavokavain B (2) were isolated from Piper rusbyi as the bioactive components by bioassay-guided fractionation, using an in vitro assay against promastigote forms of three Leishmania strains. In addition, the new kavapyrone, (7R,8R/7S,8S)-dihydroxy-5,6-didehydrokavain (3), which is very likely an artifact, and four known compounds (4-7) were isolated. Their structures were elucidated on the basis of spectral analysis, and the absolute configurations of compounds 1 and 3 were established by CD studies and the modified Mosher ester procedure, respectively. All compounds were evaluated for in vitro leishmanicidal activity. The most active compounds 1 (IC50 = 81.9 μM) and 2 (IC50 = 11.2 μM) were also evaluated in vivo against a New World strain of cutaneous leishmaniasis, and the results showed the efficacy of 2 at a dose of 5 mg/kg/day. Compounds 1 and 3 were also assayed as reversal agents against a multidrug-resistant Leishmania tropica line, but were found to be inactive.
KW - Chalcones
KW - Kavapyrones
KW - Leishmania
KW - Piper rusbyi
KW - Piperaceae
KW - Reversal of multidrug-resistance activities
UR - http://www.scopus.com/inward/record.url?scp=34250366681&partnerID=8YFLogxK
U2 - 10.1055/s-2007-967123
DO - 10.1055/s-2007-967123
M3 - Artículo
C2 - 17354169
AN - SCOPUS:34250366681
VL - 73
SP - 206
EP - 211
JO - Planta Medica
JF - Planta Medica
SN - 0032-0943
IS - 3
ER -